Search for: "Mylan Pharmaceuticals, Inc"
Results 81 - 100
of 497
Sort by Relevance
|
Sort by Date
8 May 2019, 7:14 am
” It’s not enough to put an unapproved drug on the market with a FDA-ish package insert, according to Mylan Labs., Inc. v. [read post]
13 Mar 2019, 9:10 am
Mylan Pharmaceuticals, Inc., et al., No. 18-899 (May tribal sovereign immunity may be asserted to bar IPR review of patents owned by the tribe?) [read post]
11 Mar 2019, 7:08 pm
The asymmetry of this burden is especially salient in domains like pharmaceutical drugs and biosimilars, where the incentive to test the validity of patents has important social consequences, and the complexities of those decades-long disputes create fact patterns that can be difficult to unpack. [read post]
21 Feb 2019, 9:29 pm
Mylan Pharmaceuticals Inc., No. 2018-2097 ("Valeant II"), Salix moves to disqualify in Salix Pharmaceuticals, Inc. v. [read post]
21 Feb 2019, 8:45 am
Mylan Pharmaceuticals Inc., No. 2018-2097 (“Valeant II”), Salix moves todisqualify in Salix Pharmaceuticals, Inc. v. [read post]
14 Feb 2019, 9:50 pm
RE38,551 challenged in inter partes review were not unpatentable for obviousness, in Mylan Pharmaceuticals Inc. v. [read post]
14 Feb 2019, 7:05 am
Mylan Pharmaceuticals Inc. 18-899 Issue: Whether inter partes review before the Patent Trial and Appeal Board is the type of proceeding in which tribal sovereign immunity may be asserted. [read post]
7 Feb 2019, 5:36 pm
In Momenta Pharmaceuticals, Inc. v. [read post]
6 Feb 2019, 5:15 pm
Statutory Right to Appeal for Joined Parties In Mylan Pharmaceuticals Inc. v. [read post]
4 Feb 2019, 8:59 am
Inc. v. [read post]
23 Jan 2019, 10:08 am
Mylan Pharmaceuticals, Inc., et al. [read post]
23 Jan 2019, 9:58 am
Mylan Pharmaceuticals, Inc., et al. [read post]
23 Jan 2019, 9:58 am
Mylan Pharmaceuticals, Inc., et al. [read post]
27 Dec 2018, 7:54 am
The recalled products were manufactured by some of the world’s largest pharmaceutical companies, including Teva Pharmaceuticals, Mylan Pharmaceuticals, Kimberly-Clark, Abbott and Bayer. [read post]
24 Oct 2018, 1:47 pm
Mylan Pharmaceuticals Inc., App. [read post]
12 Oct 2018, 1:24 pm
Mylan Pharmaceuticals Inc., Nos.17-1594, 17-1595, 17-1596 (Fed. [read post]
3 Oct 2018, 8:51 am
Mylan Pharmaceuticals). [read post]
10 Sep 2018, 10:17 am
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
22 Aug 2018, 7:21 am
" Noven Pharmaceuticals, Inc. v. [read post]
21 Aug 2018, 9:58 pm
Mylan Pharmaceuticals Inc., affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
